Angela Sara Philip

TAVI in low‑risk severe aortic stenosis: evidence, controversies and lifetime treatment strategy.

Transcatheter aortic valve implantation (TAVI) has expanded from a treatment for inoperable and high-risk aortic stenosis (AS) to an established therapeutic option for selected patients at low surgical risk; this review focuses on the outcomes of major trials comparing TAVI to traditional surgical aortic valve replacem...